0001185185-24-000264.txt : 20240315
0001185185-24-000264.hdr.sgml : 20240315
20240315212700
ACCESSION NUMBER: 0001185185-24-000264
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240313
FILED AS OF DATE: 20240315
DATE AS OF CHANGE: 20240315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRIMALDI CLAUDIA
CENTRAL INDEX KEY: 0001745853
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32830
FILM NUMBER: 24756771
MAIL ADDRESS:
STREET 1: PO BOX 60642
CITY: POTOMAC
STATE: MD
ZIP: 20859
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IGC Pharma, Inc.
CENTRAL INDEX KEY: 0001326205
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 202760393
STATE OF INCORPORATION: MD
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 10224 FALLS ROAD
CITY: POTOMAC
STATE: MD
ZIP: 20854
BUSINESS PHONE: 301-983-0998
MAIL ADDRESS:
STREET 1: 10224 FALLS ROAD
CITY: POTOMAC
STATE: MD
ZIP: 20854
FORMER COMPANY:
FORMER CONFORMED NAME: India Globalization Capital, Inc.
DATE OF NAME CHANGE: 20050505
4
1
ownership.xml
X0508
4
2024-03-13
0
0001326205
IGC Pharma, Inc.
IGC
0001745853
GRIMALDI CLAUDIA
10224 FALLS ROAD
POTOMAC
MD
20854
1
0
0
0
0
Common Stock
2024-03-13
4
M
0
83333
0.0
A
783821
D
Common Stock
2024-03-13
4
M
0
58333
0.0
A
842154
D
Common Stock
2024-03-13
4
M
0
100000
0.0
A
942154
D
Common Stock
2024-03-13
4
M
0
95000
0.0
A
1037154
D
Restricted Stock Units
2024-03-13
4
M
0
83333
0.0
D
Common Stock
83333
0
D
Restricted Stock Units
2024-03-13
4
M
0
58334
0.0
D
Common Stock
58334
58332
D
Restricted Stock Units
2024-03-13
4
M
0
100000
0.0
D
Common Stock
100000
200000
D
Restricted Stock Units
2024-03-13
4
M
0
95000
0.0
D
2033-03-31
Common Stock
95000
285000
D
Options
2024-03-13
4
A
0
360000
0.0
A
Common Stock
360000
360000
D
Options
2024-03-13
4
A
0
550000
0.0
A
2034-03-31
Common Stock
550000
550000
D
On July 19, 2021, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2022.
On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2023.
On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2024.
On June 20, 2023, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved.
Each restricted stock unit represents a right to receive one share of IGC common stock.
On March 13, 2024, the Reporting Person was granted Options subject to vesting equally over three years starting on March 2025. The exercise price is $0.26.
On March 13, 2024, the Reporting Person was granted Options subject to vesting according to specific milestones set by the Company's Board of Directors. The Options vest when milestones are achieved. The exercise price is $0.26.
s/ Claudia Grimaldi
2024-03-15